< Back to latest news & events

Event

Technology Transfer Primer – IP Management: AI and 5G in healthcare

December 2021

Event date: 9th December 2021

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director Dr Sofie McPherson speaking.

About the webinar

How to capitalise on the 5G healthcare revolution

This session will explore how 5G wireless technology will revolutionise the healthcare industry. 5G is promising greater bandwidth, faster speeds and lower latency, and with that, to transform industries including healthcare. Virtual patient care, remote robotic surgery and sharing of 3D medical images for diagnosis of specialists located anywhere across the globe are a few examples of transformative changes to come. 5G will not only enable new healthcare services but also improve the workflow of hospitals and healthcare professionals as they evolve from using wired networks to mobile networks. 5G is also considered to expand the wearables market further as wearables will be able to send and receive far greater amounts of data wirelessly than with 4G, providing the wearers and doctors with real-time monitoring data in volumes that will allow much more powerful insight into an individual’s health status. This session will also explore challenges of 5G in the healthcare industry including how to recognise patentable aspects of 5G implementation in the healthcare sector, data security aspects, and how patent owners of 5G technology can license patents for their technology in vertical markets such as wearables.

Date

9th December, 2021

Time

4pm HK Time/8am UK time

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article